Nano-X Imaging Ltd. (NASDAQ:NNOX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six brokerages that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, two have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $4.3333.
NNOX has been the subject of several research reports. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Nano-X Imaging in a research note on Wednesday, July 8th. Cantor Fitzgerald restated an "overweight" rating and issued a $5.00 price objective on shares of Nano-X Imaging in a report on Monday, August 17th. Alliance Global Partners cut shares of Nano-X Imaging from a "buy" rating to a "neutral" rating and cut their price objective for the company from $5.00 to $3.00 in a research note on Tuesday, July 7th. Finally, Zacks Research raised shares of Nano-X Imaging from a "strong sell" rating to a "hold" rating in a report on Monday, June 22nd.
Check Out Our Latest Analysis on Nano-X Imaging
Nano-X Imaging Trading Up 1.5%
NNOX opened at $0.88 on Thursday. The stock has a 50-day moving average price of $1.10 and a 200-day moving average price of $1.79. Nano-X Imaging has a 12-month low of $0.73 and a 12-month high of $4.71. The stock has a market capitalization of $68.83 million, a P/E ratio of -0.55 and a beta of 1.26.
Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last announced its quarterly earnings data on Thursday, June 25th. The company reported ($0.16) EPS for the quarter. The firm had revenue of $4.31 million for the quarter. Nano-X Imaging had a negative net margin of 716.44% and a negative return on equity of 70.96%. On average, equities research analysts predict that Nano-X Imaging will post -0.6 EPS for the current year.
Insider Buying and Selling at Nano-X Imaging
In other Nano-X Imaging news, CEO Erez Meltzer purchased 36,000 shares of the business's stock in a transaction on Monday, July 27th. The stock was acquired at an average cost of $0.93 per share, for a total transaction of $33,480.00. Following the completion of the transaction, the chief executive officer directly owned 36,000 shares in the company, valued at approximately $33,480. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Dan S. Suesskind purchased 50,000 shares of the business's stock in a transaction on Monday, July 27th. The shares were acquired at an average price of $0.93 per share, with a total value of $46,500.00. Following the completion of the transaction, the director owned 50,000 shares of the company's stock, valued at approximately $46,500. This trade represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 95,443 shares of company stock valued at $89,706 over the last three months. 7.74% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Nano-X Imaging
Several institutional investors have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Nano-X Imaging by 8.4% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,182 shares of the company's stock valued at $182,000 after buying an additional 2,724 shares during the period. The Manufacturers Life Insurance Company lifted its stake in Nano-X Imaging by 20.5% in the second quarter. The Manufacturers Life Insurance Company now owns 22,433 shares of the company's stock worth $116,000 after acquiring an additional 3,818 shares during the period. Russell Investments Group Ltd. lifted its stake in Nano-X Imaging by 62.1% in the third quarter. Russell Investments Group Ltd. now owns 13,787 shares of the company's stock worth $51,000 after acquiring an additional 5,283 shares during the period. BNP Paribas Financial Markets boosted its holdings in Nano-X Imaging by 64.6% in the third quarter. BNP Paribas Financial Markets now owns 19,743 shares of the company's stock valued at $73,000 after acquiring an additional 7,749 shares in the last quarter. Finally, Mariner LLC boosted its holdings in Nano-X Imaging by 70.5% in the fourth quarter. Mariner LLC now owns 20,825 shares of the company's stock valued at $58,000 after acquiring an additional 8,614 shares in the last quarter. 21.49% of the stock is currently owned by hedge funds and other institutional investors.
Nano-X Imaging Company Profile
(
Get Free Report)
Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.
The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.